1. Home
  2. NGNE vs THM Comparison

NGNE vs THM Comparison

Compare NGNE & THM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neurogene Inc.

NGNE

Neurogene Inc.

HOLD

Current Price

$23.57

Market Cap

744.9M

Sector

Health Care

ML Signal

HOLD

Logo International Tower Hill Mines Ltd. (Canada)

THM

International Tower Hill Mines Ltd. (Canada)

HOLD

Current Price

$2.14

Market Cap

722.1M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
NGNE
THM
Founded
2003
1978
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
744.9M
722.1M
IPO Year
2014
2002

Fundamental Metrics

Financial Performance
Metric
NGNE
THM
Price
$23.57
$2.14
Analyst Decision
Strong Buy
Analyst Count
10
0
Target Price
★ $77.88
N/A
AVG Volume (30 Days)
354.4K
★ 651.7K
Earning Date
11-12-2026
11-06-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 0.93
N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$280.00
Revenue Growth
N/A
★ N/A
52 Week Low
$15.93
$1.43
52 Week High
$43.66
$3.65

Technical Indicators

Market Signals
Indicator
NGNE
THM
Relative Strength Index (RSI) 33.88 39.70
Support Level $16.88 $1.87
Resistance Level $29.16 $2.44
Average True Range (ATR) 1.99 0.12
MACD -0.13 -0.04
Stochastic Oscillator 29.31 25.38

Price Performance

Historical Comparison
NGNE
THM

About NGNE Neurogene Inc.

Neurogene Inc is a clinical-stage biotechnology company committed to overcoming the limitations of neurological diseases into treatable conditions, by harnessing its proprietary transgene regulation technology, EXACT(Expression Attenuation via Construct Tuning). It is building a differentiated product portfolio of genetic medicines for rare neurological diseases with high unmet needs. The drug candidates in the company's product pipeline include NGN-401, which is in development for the treatment of Rett syndrome, using its EXACT platform, and NGN-101, a non-EXACT, conventional gene therapy development candidate for the treatment of CLN5 Batten disease, designed to deliver the CLN5 gene and packaged in an AAV9 capsid.

About THM International Tower Hill Mines Ltd. (Canada)

International Tower Hill Mines Ltd is a mining company. It is engaged in the acquisition, exploration, and development of mineral properties. The company holds interests in an exploration project, namely the Livengood Gold Project. It is located in the northwest of Fairbanks, Alaska, in the Tolovana mining district within the Tintina gold belt. The project property consists of land leased from the Alaska Mental Health Trust, several smaller private mineral leases, Alaska state mining claims purchased or located by the company, and the patented ground held by the company.

Share on Social Networks: